Advertisement

Acta Neurologica Belgica

, Volume 116, Issue 1, pp 43–46 | Cite as

Serostatus of Epstein–Barr virus in Iranian MS patients

  • Sajad Karampoor
  • Hamid Zahednasab
  • Angila Ataei Pirkouh
  • Seyed Hamid Reza Monavari
  • Sreeram Ramagopalan
  • Hossein Keyvani
Original Article

Abstract

Multiple sclerosis (MS) is a common, complex disorder. Associations of MS with Epstein–Barr virus (EBV) infection in Caucasian populations are well documented. However, in the Iranian population, previous studies have been conflicting. Sixty patients with MS and 50 healthy controls were tested for anti-EBV antibodies using chemiluminescent assays. All MS patients to be seropositive for EBV as compared to 82 % of controls (p = 0.0006). A strong, significant association of MS with EBV infection was documented, similar to studies in first world populations. Future studies should investigate the temporal sequence of infection to try to understand the cause of the recent increase in MS risk in Iran.

Keywords

Multiple sclerosis Epstein–Barr virus Serology Environmental factors Immunoglobulin Infection 

Notes

Acknowledgments

This research was funded by Iran University of Medical Sciences (IUMS). We thank all MS patients and healthy individuals for participating in our study.

Conflict of interest

The authors declare no conflict of interest.

Ethical standard

This case control study has been performed in accordance to the statue of the ethics committee of the affiliated Iran University of Medical Sciences (IUMS).

Informed consent

Informed consent obtained from all individuals participants included in this study.

References

  1. 1.
    Ramagopalan SV, Dobson R, Meier UC, Giovannoni G (2010) Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol 9(7):727–739CrossRefPubMedGoogle Scholar
  2. 2.
    Etemadifar M, Abtahi S-H, Akbari M, Murray RT, Ramagopalan SV, Fereidan-Esfahani M (2013) Multiple sclerosis in Isfahan, Iran: an update. Mult Scler Houndmills Basingstoke Engl 20(8):1145–1147CrossRefGoogle Scholar
  3. 3.
    Khaki M, Ghazavi A, Ghasami K, Rafiei M, Payani M-A, Ghaznavi-Rad E et al (2011) Evaluation of viral antibodies in Iranian multiple sclerosis patients. Neurosci Riyadh Saudi Arab 16(3):224–228Google Scholar
  4. 4.
    McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127CrossRefPubMedGoogle Scholar
  5. 5.
    Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 58(6):840–846CrossRefPubMedGoogle Scholar
  6. 6.
    Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33(11):1444–1452CrossRefPubMedGoogle Scholar
  7. 7.
    Levin LI, Munger KL, O’Reilly EJ, Falk KI, Ascherio A (2010) Primary infection with the Epstein–Barr virus and risk of multiple sclerosis. Ann Neurol 67(6):824–830PubMedCentralPubMedGoogle Scholar
  8. 8.
    Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D et al (2005) Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 293(20):2496–2500CrossRefPubMedGoogle Scholar
  9. 9.
    Ramroodi N, Niazi AA, Sanadgol N, Ganjali Z, Sarabandi V (2013) Evaluation of reactive Epstein–Barr Virus (EBV) in Iranian patient with different subtypes of multiple sclerosis (MS). Braz J Infect Dis Off Publ Braz Soc Infect Dis 17(2):156–163Google Scholar
  10. 10.
    De Paschale M, Clerici P (2012) Serological diagnosis of Epstein–Barr virus infection: problems and solutions. World J Virol 1(1):31–43PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J et al (2009) Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 73(1):32–38PubMedCentralCrossRefPubMedGoogle Scholar
  12. 12.
    Etemadifar M, Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Nasr Z (2014) Estimated prevalence and incidence of multiple sclerosis in Iran. Eur Neurol 72(5–6):370–374CrossRefPubMedGoogle Scholar

Copyright information

© Belgian Neurological Society 2015

Authors and Affiliations

  • Sajad Karampoor
    • 1
  • Hamid Zahednasab
    • 2
  • Angila Ataei Pirkouh
    • 3
  • Seyed Hamid Reza Monavari
    • 3
  • Sreeram Ramagopalan
    • 4
  • Hossein Keyvani
    • 3
  1. 1.Department of Virology, School of Public HealthTehran University of Medical SciencesTehranIran
  2. 2.Institute of Biochemistry and BiophysicsThe University of TehranTehranIran
  3. 3.Department of Virology, School of MedicineIran University of Medical SciencesTehranIran
  4. 4.Medical Research Council Functional Genomics Unit and Department of Physiology, Anatomy and GeneticsUniversity of OxfordOxfordUK

Personalised recommendations